Michael
W. Jann, Pharm.D., FCP, FCCP is Professor and Chair for the Department of
Pharmacotherapy at the University of North Texas System College of Pharmacy
(UNTSCP) located at the UNT Health Sciences Center (UNTHSC). Professor Jann
received his Doctor of Pharmacy degree from the University of Southern California
and post-doctoral training in mental health pharmacy practice at the University
of Tennessee Memphis College of Pharmacy. He has published over 230 peer-review
articles, abstracts, and book chapters and served as a primary investigator for
numerous clinical trials in psychopharmacology. Professor Jann serves on the
editorial boards of six peer-review scientific journals including CNS Drugs,
Molecular Diagnostics and Therapeutics, The Scientific World Journal –
Pharmacology Section, The Consultant Pharmacist, Journal of Clinical
Pharmacology, and Journal of Pharmacy Practice.Scott R. Penzak, Pharm.D., FCP, is Professor and
Vice Chair for the Departmentof Pharmacotherapy at the University of North
Texas System College of Pharmacy (UNTSCP) located at the UNT Health Sciences
Center (UNTHSC). Professor Penzak received his Doctor of Pharmacy degree from
Wayne State University and completed his post-doctoral training in infectious
diseases at the University of Arkansas for Medical Science (UAMS). Prior to
UNTSCP, he was the Director of the Clinical Pharmacokinetics Laboratory at the NIH. He has published over 150 peer-review articles,
abstracts, and book chapters, and served as a principal investigator on
numerous pharmacokinetic and pharmacogeneticstudies. Professor Penzak serves on
the editorial boards of three peer-review scientific journals including Journal
of Clinical Pharmacology, Pharmacotherapy, and the International Journal of
Pharmacokinetics.Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP,
FCP, FNAP is currently Professor of Pharmacotherapy at the University of North
Texas System College of Pharmacy. Examples of Professor Cohen’s previous
service include, Global Director of CNS Research for Kendle International,
Director of the Office of Clinical Trials for University of Cincinnati, and
Director of Pharmaceutical Services for the Oklahoma Department of Mental
Health and Substance Abuse Services. Professor Cohen received his Doctor of Pharmacy
degree and post-doctoral training in psychiatric pharmacy from University of
Southern California School of Pharmacy. Professor Cohen has been a Board
Certified Psychiatry Pharmacist since the specialty was recognized. His relevant service on Editorial Boards include Current
Psychiatry, Innovations in Clinical Neuroscience, Primary Care Companion of the
Journal of Clinical Psychiatry, Drug Benefit Trends, Journal of the American
Medical Directors Association, CNS News and Pharmacy Practice News.